Hemphill v. Kimberly-Clark Corp.Hemphill v. Kimberly-Clark Corp.
MEMORANDUM OPINION
On July 10, 2007, Plaintiff Allegra D. Hemphill, proceeding
pro se,
filed a complaint against Kimberly-Clark Corporation and Procter & Gamble Company (collectively, “Defendants”). The Complaint alleges that Defendants infringed one claim of Ms. Hemphill’s patent in violation of
I. BACKGROUND
On December 10, 1985, Ms. Hemphill was issued a patent for a “vaginal swab.” See Compl. ¶ 7 & Ex. A (United States Patent No. 4,557,720 (“the '720 patent”)). The '720 patent describes a disposable vaginal swab or refresher meant either to cleanse or treat the vaginal area with fragrances, medications, germicides, or deodorants. Compl. Ex. A, Col. 1, lines 33-38. The '720 patent is comprised of two independent claims (hereinafter, “Claim 1” and “Claim 2”).
In March 1999, Ms. Hemphill sued Johnson
&
Johnson, Inc. for, alleged infringement of the. '720 patent in the United States District Court for the District of Maryland. Ms. Hemphill alleged that McNeil-PPC, a subsidiary of Johnson & Johnson, Inc., had infringed Claim 2. The accused products were McNeil-PPC’s sanitary napkins and adult incontinence products sold under the Stayfree, Carefree, and Serenity product lines. The Maryland District Court granted summary judgment of non-infringement for the defendant.
Hemphill v. McNeil-PPC, Inc.,
On November 18, 2002, Ms. Hemphill proceeded to sue Defendants, Kimberly-Clark Corporation and Procter
&
Gamble Company, for alleged infringement of Claim 1 of the '720 patent. She fared no better, as the court granted summary judgment in favor of Defendants.
Hemp-hill v. Procter & Gamble Co.,
In the instant Complaint, Ms. Hemphill again sues Kimberly-Clark Corporation and Procter & Gamble Company and the accused products are the same products that were at issue in Hemphill II. However, Ms. Hemphill now argues that those products infringe Claim 2 of the '720 patent. See Compl. ¶¶ 16-17.
II. LEGAL STANDARDS
A. Rule 12(b)(6)
Defendants move to dismiss Ms. Hemp-hill’s Complaint pursuant to
B. Res Judicata
Under the doctrine of
res judica-ta,
also known as claim preclusion, “a judgment on the merits in a prior suit bars a second suit involving identical parties or their privies based on the same cause of action.”
Apotex, Inc. v. FDA,
“Whether two cases implicate the same cause of action turns on whether they share the same ‘nucleus of facts.’ ”
Drake,
Res judicata
is an affirmative defense that is generally pleaded in a defendant’s answer, but is also properly brought in a pre-answer
III. ANALYSIS
As is readily apparent
from
the face of the Complaint in conjunction with the decision in
Hemphill II,
of which the Court takes judicial notice, this case involves the same defendants and products that were at issue in
Hemphill II. Compare
Del’s Mem. Ex. 1 at ¶ 13
with
Compl. ¶¶ 16-17. Ms. Hemphill makes no assertion to the contrary. It is therefore of no moment that she now accuses Defendants of infringement of Claim 2, for the “nucleus of facts” is identical in both suits.
See Foster v. Hallco Mfg. Co.,
IV. CONCLUSION
For the foregoing reasons, Defendants’ Motion to Dismiss [Dkt. # 4] will be granted and this case will be dismissed with prejudice. All other pending motions will be denied as moot. A memorializing order accompanies this Memorandum Opinion.